Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID05832528

The Effect of a Low FODMAP Diet in Functional Dyspepsia Patients With Meal Related Symptoms on Complaint Pattern and Urinary Histamine Excretion

Led by Universitaire Ziekenhuizen KU Leuven · Updated on 2024-07-01

30

Participants Needed

1

Research Sites

6 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying the effects of a low-FODMAP diet on patients with functional dyspepsia (FD), a condition causing upper digestive symptoms like fullness, pain, and burning without an obvious organic cause. The study aims to see if this diet can reduce these symptoms and understand how it might work, focusing on duodenal changes and urinary histamine levels related to FD. Functional dyspepsia is common and can significantly impact daily life and healthcare costs, especially in patients with severe symptoms and psychosocial effects. Participants will follow a structured dietary plan starting with a 2-week baseline period, followed by 6 weeks on a strict low-FODMAP diet. Next, a 5-week single-blind reintroduction phase tests individual FODMAP groups and a control substance. Finally, a 2-week moderate FODMAP diet phase allows consumption of non-triggering FODMAPs. The study provides educational materials and recipes to support diet adherence. Urine samples and duodenal biopsies are collected before and after the strict diet to examine physiological changes. During the study, participants will have symptom assessments using the Leuven-postprandial distress scale before and after the diet. Researchers will measure urinary histamine, N-methylhistamine, duodenal mucosal integrity, and low-grade inflammation to explore diet effects. Endoscopies and 24-hour urine collections occur at baseline and after six weeks. The total participation includes about 15 weeks of dietary phases and monitoring, allowing detailed evaluation of symptom changes and biological responses.

CONDITIONS

Brief Title

Low FODMAP Diet in FD (PDS)

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with functional dyspepsia or postprandial distress syndrome diagnosed by Rome IV criteria
  • Symptom characteristics of dyspepsia occurring in the last 6 months and meal related
  • Negative endoscopy within the past 12 months
  • Provided witnessed written informed consent before any study procedures
  • Patients aged between 18 and 70 years inclusive
  • Male or female patients
Not Eligible

You will not qualify if you...

  • Any condition making the patient unsuitable for study entry as judged by the investigator
  • Major psychiatric disorders, depression, alcohol or substance abuse within the last 2 years
  • Predominant symptoms of irritable bowel syndrome (IBS) or gastro-oesophageal reflux disease (GERD)
  • Changed diet in the last 3 months or previous use of the low FODMAP diet
  • Females who are pregnant or breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Run-in Period

Duration - 2 weeks

Participants follow a 2-week baseline period to establish symptom and urinary histamine levels before starting the diet.

Visits as needed for baseline measurements

Treatment

Duration - 6 weeks

Participants follow a 6-week strict low FODMAP diet to evaluate its effect on gastrointestinal symptoms and urinary histamine excretion.

Regular visits for diet support and assessments

Treatment

Duration - 5 weeks

Participants undergo a 5-week single-blind reintroduction phase where different FODMAP groups are challenged sequentially to identify symptom triggers.

Several visits or check-ins for symptom monitoring during challenges

Treatment

Duration - 2 weeks

Participants follow a 2-week moderate FODMAP diet based on tolerated foods identified during reintroduction.

Visits or contacts for final assessments

Trial Site Locations

Total: 1 location

1

KU Leuven

Leuven, Vlaams-Brabant, Belgium, 3000

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

Hypermobile Ehlers-Danlos Syndrome: Efficacy of Non-invasive...

Functional Gastrointestinal Disorders

Actively Recruiting

1 location

Body Surface Gastric Mapping (BSGM) to Evaluate Patients Wit...

Gastrointestinal Motility Disorders in Children

Actively Recruiting

5 locations

Capsule Microbiota Sampling in IBS and Functional Gastrointe...

IBS - Irritable Bowel Syndrome

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Validity of a new quality of life scale for functional dyspepsia: a United States multicenter trial of the Nepean Dyspepsia Index.

N J Talley, M Verlinden, M Jones

https://pubmed.ncbi.nlm.nih.gov/10483997

The Intragastric Pressure Measurement: A Novel Method to Assess Gastric Accommodation in Functional Dyspepsia Children.

Florencia Carbone, Jan Tack, Ilse Hoffman

https://pubmed.ncbi.nlm.nih.gov/27557427